Antibody response to merkel cell polyomavirus associated with incident lymphoma in the epilymph case-control study in Spain

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 9, 2012, Pages 1592-1598

  Robles, Claudia ^a   Poloczek, Andre ^b   Casabonne, Delphine ^a,c   Gonzalez Barca, Eva ^a   Bosch, Ramon ^d   Benavente, Yolanda ^a,c   Viscidi, Raphael P ^b   De Sanjosé, Silvia ^a,c  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL VERGE DE LA CINTA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP1; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; B CELL LYMPHOMA; CANCER INCIDENCE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; PRIORITY JOURNAL; SEROPREVALENCE; SPAIN; T CELL LYMPHOMA; VIRUS LIKE AGENT; WALDENSTROEM MACROGLOBULINEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CAPSID PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENTAL FINDINGS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MERKEL CELL POLYOMAVIRUS; MIDDLE AGED; SPAIN;

EID: 84866163336     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1140     Document Type: Article

References (32)

1. Scuda N, Hofmann J, Calvignac-Spencer S, Ruprecht K, Liman P, Kuhn J, et al. A novel human polyomavirus closely related to the African green monkey-derived lymphotropic polyomavirus (LPV). J Virol 2011;85:4586-90.
2. Gjoerup O, Chang Y. Update on human polyomaviruses and cancer. Adv Cancer Res 2010;106:1-51.
3. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-100.
4. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009;5:e1000363.
5. Touze A, Gaitan J, Arnold F, Cazal R, Fleury MJ, Combelas N, et al. Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol 2010;48:1767-70.
6. Viscidi RP, Rollison DE, Sondak VK, Silver B, Messina JL, Giuliano AR, et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011;18:1737-43.
7. Paulson KG, Carter JJ, Johnson LG, Cahill KW, Iyer JG, Schrama D, et al. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients. Cancer Res 2010;70:8388-97.
8. Carter JJ, Paulson KG, Wipf GC, Miranda D, Madeleine MM, Johnson LG, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009;101:1510-22.
9. Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, Moschos S, et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009;125:1250-6.
10. Pastrana DV, Tolstov YL, Becker JC, Moore PS, Chang Y, Buck CB. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009;5:e1000578.
11. Touze A, Le BE, Laude H, Fleury MJ, Cazal R, Arnold F, et al. High levels of antibodies against Merkel cell polyomavirus identify a subset of patients with Merkel cell carcinoma with better clinical outcome. J Clin Oncol 2011;29:1612-9.
12. Tadmor T, Aviv A, Polliack A. Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 2011;22:250-6.
13. Toracchio S, Foyle A, Sroller V, Reed JA, Wu J, Kozinetz CA, et al. Lymphotropism of Merkel cell polyomavirus infection, Nova Scotia, Canada. Emerg Infect Dis 2010;16:1702-9.
14. Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 2009;125:1243-9.
15. Teman CJ, Tripp SR, Perkins SL, Duncavage EJ. Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Res 2011;35:689-92
16. Andres C, Puchta U, Sander CA, Ruzicka T, Flaig MJ. Prevalence of Merkel cell polyomavirus DNA in cutaneous lymphomas, pseudolymphomas, and inflammatory skin diseases. Am J Dermatopathol 2010;32:593-8
17. Pantulu ND, Pallasch CP, Kurz AK, Kassem A, Frenzel L, Sodenkamp S, et al. Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood 2010;116:5280-4.
18. Haugg AM, Speel EJ, Pantulu ND, Pallasch C, Kurz AK, Kvasnicka HM, et al. Fluorescence in situ hybridization confirms the presence of Merkel cell polyomavirus in chronic lymphocytic leukemia cells. Blood 2011;117:5776-7.
19. Zur Hausen A. Opening new roads for MCPyV. Blood 2011;117:6975-6.
20. Tolstov YL, Arora R, Scudiere SC, Busam K, Chaudhary PM, Chang Y, et al. Lack of evidence for direct involvement of Merkel cell polyomavirus (MCV) in chronic lymphocytic leukemia (CLL). Blood 2010;115:4973-4.
21. de Sanjose S, Shah KV, Domingo-Domenech E, Engels EA, Fernandez de Sevilla A, Alvaro T, et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer. 2003;104:522-4.
22. Swerdlow S, Campo E, Harris N. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.
23. Viscidi RP, Rollison DE, Viscidi E, Clayman B, Rubalcaba E, Daniel R, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003;10:278-85.
24. Randhawa PS, Gupta G, Vats A, Shapiro R, Viscidi RP. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 2006;13:1057-63.
25. Viscidi RP, Khanna N, Tan CS, Li X, Jacobson L, Clifford DB, et al. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis 2011;53:711-5.
26. Pratt G, Goodyear O, Moss P. Immunodeficiency and immunotherapy in multiple myeloma. Br J Haematol 2007;138:563-79.
27. de Sanjose S, Nieters A, Goedert JJ, Domingo-Domenech E, Fernandez de Sevilla A, Bosch R, et al. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer 2004;111:81-5.
28. de Sanjose S, Goedert JJ, Marshall V, Bellas C, Benavente Y, Bosch R, et al. Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain. Br J Cancer 2004;90:2145-8.
29. de Sanjose S, Dickie A, Alvaro T, Romagosa V, Garcia-Villanueva M, Domingo-Domenech E, et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiol Biomarkers Prev 2004;13:944-8.
30. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest 2011;121:3623-34.
31. Kodali D, Rawal A, Ninan MJ, Patel MR, Mesa H, Knapp D, et al. Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues. Arch Pathol Lab Med 2011;135:365-71.
32. El Salem M, Raghunath PN, Marzec M, Liu X, Kasprzycka M, Robertson E, et al. Activation of mTORC1 signaling pathway in AIDS-related lymphomas. Am J Pathol. 2009;175:817-24.